
Histology and Cytology IVD Market Update, 2024
Description
Histology and Cytology IVD Market Update, 2024
This report, Histology and Cytology IVD Market Update, 2024, provides competitive analysis of the histology/cytology market from 2023 to 2028. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination. Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the knowledge and understanding of the shape-function relationships within tissues and organs and their relationship to disease.
The industry has forged ahead with new technologies that offer increased accuracy and automated workflow. In the coming years, digital imaging, quantitative microscopy, precision microscopy, artificial intelligence and virtual histology will take the histology/cytology industry to the next level.
As discussed in the report, the histology market is a growing market with much potential. This report only looks at traditional histology. The histology report is segmented into five areas:
- Traditional non-PAP Stains
- PAP
- In situ Hybridization
- Immunohistochemistry
- HPV
- Agilent
- Danaher Corporation
- Hologic
- Illumina
- Roche Diagnostics
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2023. Data are provided for 2023 and 2028 with compound annual growth rates (CAGRs) for 2023 and 2028. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, Europe, Asia-Pacific and Rest of World for 2023. The forecasted market analysis for 2023-2028 was largely based on demographic trends, new developments, innovative technology and global expansion.
Table of Contents
80 Pages
- Industry at a Glance
- Scope and Methodology
- Size and Growth of the Market
- Competitive Outlook
- Overview Of Histology/Cytology
- Histology and Cancer
- Advanced Analysis Solutions
- Laboratory Developed Tests
- AI and Histology
- Market Segments
- Market by Region
- Competitive Analysis
- The Commercial Outlook for Histology
- Abbott Diagnostics
- Agilent
- Becton, Dickinson and Company
- Biocare Medical
- BioGenex
- Danaher Corporation
- Hologic
- Illumina, Inc
- Medimeas
- QIAGEN N.V.
- Roche Diagnostic (Roche Tissue Diagnostics)
- Sysmex
- Thermo Fisher Scientific
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.